Quick Answer
Omada Health, Inc. reported Cash and Equivalents of $222.04 million for fiscal year 2025.
Omada Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $222.04M | +190.7% |
| 2024 | $76.39M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $198.63M | — | -11.0% |
| June 30, 2025 | $223.15M | — | +192.1% |
| December 31, 2024 | $76.39M | — | — |
- Omada Health, Inc. showed an increase of +190.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2024–2025 period, Omada Health, Inc.’s cash and equivalents has grown by 190.7% (from $76.39 million to $222.04 million).
- The most recent figure is from Omada Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: